A Phase 3 Study of NE3107 in Probable Alzheimer's Disease

NCT04669028 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

439

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: NE3107
DRUG: Placebo

Sponsor

BioVie Inc.